Latest Articles
Oct 7, 2026
•
9 min read
Three AI tools graded, a drug’s “younger” claim tested, and why AI drugs stall.
Oct 4, 2026
6 min read
I expected the AI drugs to be failing early. Odd chemistry from a black box, the sort of molecule that falls over the first time it meets a human liver. That’s not what the data showed.
Sep 30, 2026
7 min read
Three ways to protect bone graded, and a 94% stem-cell headline put in context.
Sep 27, 2026
Why weight loss thins bone, when the scan misleads, and how to tell whether your own result has really changed.
Sep 23, 2026
5 min read
Muscle size isn’t the asset. Strength is. Three muscle protectors graded, plus the ‘40% is muscle’ scare checked against MRI.
Sep 21, 2026
Why strength drifts away from size, what the weight-loss numbers really show, and how to tell whether your own results have changed.
Sep 16, 2026
Generative AI, peptide design and digital twins are speeding discovery. Here is where the shortcut stops.
Sep 13, 2026
How generative design, digital twins and human trials fit together, and where the shortcut stops.
Sep 9, 2026
One trial, three clocks, different answers. What to ask before paying for a younger number.
Sep 6, 2026
What the number means, why it can move, and when it should change a decision.
Sep 2, 2026
Wall squats beat running, salt beat a drug trial, and a Class 3 verdict on your wrist.
Sep 1, 2026
8 min read
Five compounds, five different ways the evidence gives way — and three rules you can take to any peptide claim you meet next.
Apr 6, 2026
And Why Yours Doesn’t Have to Be Different
Mar 31, 2026
How your cells take out the rubbish — and what happens when they stop
The Repair Enzymes at the Heart of Longevity Science
14 min read
Your cells’ power plants degrade with age. Here’s what the science says about slowing it down
One of the central drivers of age-related disease. It’s fuelled by senescent cells secreting inflammatory signals
Feb 4, 2026
13 min read
How one ancient enzyme connects exercise, fasting, and the most studied longevity drugs — and why more activation isn’t always better.